Brevan Howard Capital Management’s Spyre Therapeutics SYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-16,899
Closed -$393K 1401
2024
Q4
$393K Buy
+16,899
New +$393K ﹤0.01% 669